Targeted Anti-cancer Therapies (TAT) conference roundup

Name: Targeted Anti-cancer Therapies (TAT) conference roundup
Uploaded: 2014-04-22T00:00:00+00:00
Description: Prof Gordon McVie of ecancer and European Institute of Oncology, Milan, Italy gives a roundup of the 12th International Congress on Targeted Anti-cancer Therapies (TAT) conference.

Published: 22 Apr 2014

Rating:

Save

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Prof Gordon McVie of ecancer and European Institute of Oncology, Milan, Italy gives a roundup of the 12th International Congress on Targeted Anti-cancer Therapies (TAT) conference.

Related Videos

ASCO GU 2026: Updates in metastatic prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina

17 Mar 2026

ASCO GU 2026: Updates in localised prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina

17 Mar 2026

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Dr Elias Mai - Heidelberg University, Heidelberg, Germany

28 Oct 2024

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

30 Sep 2024

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

16 Sep 2024

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma

Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA

$Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma ( Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA )$